These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 20051874)
1. Pairwise comparison of isogenic HIV-1 viruses: R5 phenotype replicates more efficiently than X4 phenotype in primary CD4+ T cells expressing physiological levels of CXCR4. Fiser AL; Lin YL; Portalès P; Mettling C; Clot J; Corbeau P J Acquir Immune Defic Syndr; 2010 Feb; 53(2):162-6. PubMed ID: 20051874 [TBL] [Abstract][Full Text] [Related]
2. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation. Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841 [TBL] [Abstract][Full Text] [Related]
3. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection. Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743 [TBL] [Abstract][Full Text] [Related]
4. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells. Roy AM; Schweighardt B; Eckstein LA; Goldsmith MA; McCune JM J Acquir Immune Defic Syndr; 2005 Nov; 40(3):267-75. PubMed ID: 16249699 [TBL] [Abstract][Full Text] [Related]
5. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. Schmitt N; Chêne L; Boutolleau D; Nugeyre MT; Guillemard E; Versmisse P; Jacquemot C; Barré-Sinoussi F; Israël N J Virol; 2003 May; 77(10):5784-93. PubMed ID: 12719571 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501 [TBL] [Abstract][Full Text] [Related]
8. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines. Mariani SA; Brigida I; Kajaste-Rudnitski A; Ghezzi S; Rocchi A; Plebani A; Vicenzi E; Aiuti A; Poli G Blood; 2012 Mar; 119(9):2013-23. PubMed ID: 22234680 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells. Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935 [TBL] [Abstract][Full Text] [Related]
11. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1. Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754 [TBL] [Abstract][Full Text] [Related]
12. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. Toma J; Whitcomb JM; Petropoulos CJ; Huang W AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728 [TBL] [Abstract][Full Text] [Related]
13. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells. Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Penn ML; Grivel JC; Schramm B; Goldsmith MA; Margolis L Proc Natl Acad Sci U S A; 1999 Jan; 96(2):663-8. PubMed ID: 9892690 [TBL] [Abstract][Full Text] [Related]
15. N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. Wang J; Babcock GJ; Choe H; Farzan M; Sodroski J; Gabuzda D Virology; 2004 Jun; 324(1):140-50. PubMed ID: 15183061 [TBL] [Abstract][Full Text] [Related]
16. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains. Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703 [TBL] [Abstract][Full Text] [Related]
18. A CCR5 Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function. Dejucq N J Leukoc Biol; 2000 Sep; 68(3):331-7. PubMed ID: 10985248 [TBL] [Abstract][Full Text] [Related]
20. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Grivel JC; Margolis LB Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]